Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Metabolites|July 27, 2022
Crosstalk between Host Genome and Metabolome among People with HIV in South AfricaChang Liu, Zicheng Wang, Qin Hui, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries with the Highest Adult HIV PrevalenceCameron T Nutt, Richard J Lessells, Winnie R Muyindike, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled TrialSean Wasserman, Angharad Davis, Cari Stek, et al.
Public Health Action|July 3, 2024
Depression: an individual-level early warning indicator of virologic failure in HIV patients in South AfricaJ A Edwards, J Brijkumar, M Dudgeon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 4, 2025
Factors Associated with Incomplete Adherence to Dolutegravir-Based Antiretroviral Therapy in Southwestern UgandaCameron T Nutt, Winnie R Muyindike, Victoria Nanfuka, et al.
Virus Evolution|February 16, 2024
SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutationsGila Lustig, Yashica Ganga, Hylton E Rodel, et al.
The Journal of Infectious Diseases|May 15, 2024
Population Effectiveness of Dolutegravir Implementation in Uganda: A Prospective Observational Cohort Study (DISCO), 48-Week ResultsSuzanne M McCluskey, Winnie R Muyindike, Victoria Nanfuka, et al.
Annals of Internal Medicine|October 26, 2021
Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa : An Unblinded Randomized Controlled TrialMark J Siedner, Mahomed-Yunus S Moosa, Suzanne McCluskey, et al.
Virus Evolution|March 26, 2026
Evolution and viral properties of the SARS-CoV-2 BA.3.2 subvariantZesuliwe Jule, Cornelius Römer, Taskeen Hossen, et al.
AIDS (London, England)|March 20, 2024
Regional variation in weight change after the transition to dolutegravir in Uganda and South AfricaRichard Migisha, Geoffrey Chen, Winnie R Muyindike, et al.
Pageof 13